Reportedly, the DEA has officially lifted the restrictions against the use of electronic prescribing for controlled substances (schedule II – schedule V), which have been the single greatest barrier to e-prescribing adoption over the last 10 years
The Drug Enforcement Administration’s (DEA) regulations which takes effect from June 1, allows prescribers the option to write prescriptions for controlled substances electronically and allow pharmacies to receive, dispense, and archive these electronic prescriptions.
The regulations are an addition to existing rules and will maintain a closed system of controls on controlled substances dispensing. In addition, the regulations help in reduction of prescription errors and will help integrate prescription records into other medical records.
Peter Kaufman, CMO of DrFirst, said: “We created a process that not only uses tight security for prescribers using the system, but uses the current trusted network between the e-prescribing or EMR application and the pharmacy. This new Rcopia system will finally allow providers to efficiently adopt an optimal e-prescribing workflow in their offices with a complete e-prescribing solution.”